News

Clínic Barcelona

Research November 15 2024

Participation of the Clínic-IDIBAPS in one of the projects selected in the CaixaResearch call for Health Research 2024

Over the next three years, the chosen project, led by Roger Gomis (IRB) in consortium with Aleix Prat (Clínic-IDIBAPS), will study the factors that c1

Clínic Barcelona

Research October 31 2024

Updated findings on dual HER2 inhibition in HER2+ breast cancer

Researchers from the Clínic-IDIBAPS, along with researchers from the Dana Farber Cancer Institute (DFCI) in Boston, have published a review on dual H1

Clínic Barcelona

Institutional October 21 2024

Researchers from the Clínic-IDIBAPS recognized with various grants at the SEOM congress

Five researchers from the Clínic-IDBAPS were recognized with various grants worth a total of €122,000 at the Spanish Society of Medical Oncology (SEO1

Clínic Barcelona

Research September 30 2024

Researchers analyse the efficacy of immunotherapy combined with chemotherapy in the treatment of early breast cancer

Researchers from the Clínic-IDIBAPS have coordinated a study that analyses the efficacy of anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs) combin1

Clínic Barcelona

Research September 19 2024

Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024

One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet’s1

page1 , current page.
page2
page3
page4
page5
page 6
page 7

News

Participation of the Clínic-IDIBAPS in one of the projects selected in the CaixaResearch call for Health Research 2024

Updated findings on dual HER2 inhibition in HER2+ breast cancer

Researchers from the Clínic-IDIBAPS recognized with various grants at the SEOM congress

Researchers analyse the efficacy of immunotherapy combined with chemotherapy in the treatment of early breast cancer

Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024

navigation between pages below